Clincosm LogoSign in Get a demo

Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
  • +2 more
  • Torrance, California
  • +25 more
Sep 28, 2023

COPD Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Benralizumab
  • Placebo
  • Montgomery, Alabama
  • +400 more
Jan 11, 2023

COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Itepekimab SAR440340
  • Placebo
  • Palm Springs, California
  • +231 more
Dec 19, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Peoria, Arizona
  • +133 more
Dec 5, 2022

Observational Study of Obstructive Lung Disease (NOVELTY)

Active, not recruiting
  • Asthma
  • +2 more
  • Blood draw
  • +3 more
  • Loma Linda, California
  • +302 more
Nov 22, 2022

COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Los Angeles, California
  • +82 more
Oct 28, 2022

COPD Trial in Worldwide (Astegolimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Andalusia, Alabama
  • +170 more
Aug 4, 2022

REported Outcomes in COPD With Trixeo in Real worlD in Germany

Recruiting
  • Chronic Obstructive Pulmonary Disease
    • Auerbach, Germany
    • +31 more
    Jul 12, 2022

    COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • Dupilumab SAR231893
    • +4 more
    • Cullman, Alabama
    • +334 more
    Jun 14, 2022

    COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

    Active, not recruiting
    • Chronic Obstructive Pulmonary Disease
    • Dupilumab SAR231893
    • +4 more
    • Andalusia, Alabama
    • +286 more
    May 11, 2022

    COPD Trial in Worldwide (CHF 5259, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • CHF 5259
    • Placebo
    • Sevlievo, Bulgaria
    • +28 more
    Oct 28, 2021

    Chronic Bronchitis, COPD Trial in Worldwide (ION-827359, Placebo)

    Terminated
    • Chronic Bronchitis
    • Chronic Obstructive Pulmonary Disease
    • Jindrichuv Hradec, Czechia
    • +14 more
    May 11, 2021

    COPD Trial in Germany, Netherlands (Concept2 inhaler, Concept2 inhaler with patient application)

    Terminated
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • Concept2 inhaler
    • Concept2 inhaler with patient application
    • Berlin, Germany
    • +8 more
    Dec 9, 2020

    COPD Trial in Berlin, Mannheim, Wiesbaden (QAT370, Placebo, Tiotropium)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Berlin, Germany
    • +2 more
    Dec 16, 2020

    COPD Trial in Germany, United Kingdom (AZD8871, Anoro® Ellipta®)

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • Berlin, Germany
    • +4 more
    Nov 24, 2020

    COPD Trial in Berlin (Abediterol (2.4 µg), Abediterol (4.8 µg), Abediterol (2.5 µg))

    Terminated
    • Chronic Obstructive Pulmonary Disease
    • Abediterol (2.4 μg)
    • +2 more
    • Berlin, Germany
      Research Site
    Apr 20, 2020

    COPD Trial in Germany (ACT-541468, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Berlin, Germany
    • +4 more
    Sep 20, 2019

    COPD Trial in Worldwide (JNJ 49095397, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • JNJ 49095397
    • Placebo
    • Phoenix, Arizona
    • +48 more
    Aug 19, 2019

    COPD Trial in Worldwide (NVA237, Placebo, Salbutamol)

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • Genk, Limburg, Belgium
    • +80 more
    Jun 21, 2019

    Asthma, COPD Trial in Berlin, Harrow (Benralizumab)

    Completed
    Has Results
    • Asthma
    • Chronic Obstructive Pulmonary Disease
    • Benralizumab
    • Berlin, Germany
    • +1 more
    Jul 3, 2019

    COPD Trial in Worldwide (GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001))

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • GFF MDI (PT003)
    • +3 more
    • Andalusia, Alabama
    • +166 more
    Jan 28, 2019

    COPD Trial in Germany

    Completed
    • Chronic Obstructive Pulmonary Disease
      • Aachen, D6570r00001, Germany
      • +179 more
      Dec 10, 2018

      COPD Trial in Worldwide (Aclidinium bromide 400 µg/Formoterol Fumarate 12 µg (AB/FF 400/12 µg), Aclidinium bromide 400 µg (AB

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease
      • Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
      • +5 more
      • Gulf Shores, Alabama
      • +162 more
      Nov 7, 2018

      Obesity Hypoventilation Syndrome, Obstructive Sleep Apnea, COPD Trial in Berlin (Simplus/Eson)

      Terminated
      • Obesity Hypoventilation Syndrome
      • +3 more
      • Simplus/Eson
      • Berlin, Germany
        Charité - Universitätsmedizin Berlin
      Jul 31, 2018

      COPD Trial in Worldwide (Lebrikizumab, Placebo)

      Completed
      • Chronic Obstructive Pulmonary Disease
      • Birmingham, Alabama
      • +65 more
      Sep 5, 2017